Skip to main content
Download PDF

Knockdown of myorg leads to brain calcification in zebrafish

Molecular Brain volume 15, Article number: 65 (2022) Cite this article

Abstract

Primary familial brain calcification (PFBC) is a neurogenetic disorder characterized by bilateral calcified deposits in the brain. We previously identified that MYORG as the first pathogenic gene for autosomal recessive PFBC, and established a Myorg-KO mouse model. However, Myorg-KO mice developed brain calcifications until nine months of age, which limits their utility as a facile PFBC model system. Hence, whether there is another typical animal model for mimicking PFBC phenotypes in an early stage still remained unknown. In this study, we profiled the mRNA expression pattern of myorg in zebrafish, and used a morpholino-mediated blocking strategy to knockdown myorg mRNA at splicing and translation initiation levels. We observed multiple calcifications throughout the brain by calcein staining at 2–4 days post-fertilization in myorg-deficient zebrafish, and rescued the calcification phenotype by replenishing myorg cDNA. Overall, we built a novel model for PFBC via knockdown of myorg by antisense oligonucleotides in zebrafish, which could shorten the observation period and replenish the Myorg-KO mouse model phenotype in mechanistic and therapeutic studies.

Introduction

Brain calcification is often observed in the elderly. Its prevalence is higher in individuals with Parkinson’s disease, Alzheimer’s disease, and Down’s syndrome [1, 2]. The prevalence of brain calcification is estimated to be 6.6 per 1000 or higher in China [3]. Primary familial brain calcification (PFBC), also known as idiopathic basal ganglia calcification (IBGC) or Fahr’s disease, is a genetic neurodegenerative disorder that features bilateral symmetric brain calcification most prominently in the basal ganglia, thalamus, cerebellum, and subcortical white matter [4]. Among those tissues, the basal ganglia are the most likely to be affected, especially the globus pallidus. The clinical manifestations of PFBC vary and include motor disorders, psychiatric symptoms, cognitive impairment, seizures, migraine, dizziness, and can even be asymptomatic [5]. The brain calcification of PFBC autopsy samples detected by electron microscopy indicated that deposits were composed of a mixture of glycoproteins, mucopolysaccharides, calcium salts, and iron [6].

In recent years, six pathogenic genes have been identified for PFBC: SLC20A2, PDGFRB, PDGFB, XPR1, MYORG, and JAM2 [7,8,9,10,11,12]. Of the six causative genes, SLC20A2 and XPR1 are both phosphate transporters that play prominent roles in maintaining Ca-P homeostasis [13, 14]. PDGFRB and PDGFB encode a receptor and ligand in the mural cells (pericytes and smooth muscle cells) and endothelial cells which are associated with blood-brain barrier (BBB) integrity [15]. MYORG, a putative glycosidase, was specifically located in astrocytes. [11]. Moreover, JAM2 encodes a protein participating in a tight junction in the endothelial cells [16].

We first reported that biallelic MYORG mutations are the cause of autosomal recessive PFBC [11]. Clinically, PFBC patients with MYORG mutations mostly suffer from motor disorders (such as dysarthria, dysphagia, dystonia, parkinsonism, and ataxia), cognitive impairment, psychiatric symptoms, seizures, and dizziness. Their brain CT images consistently showed bilateral calcifications in the basal ganglia, dentate nucleus of cerebellum, subcortical white matter, and brainstem, etc. MYORG was originally identified from a proteomic analysis as a nuclear envelope transmembrane protein with glycosidase homology [17]. MYORG is also necessary for myogenic differentiation [18, 19]. We next detected that Myorg mRNA is largely localized to astrocytes, particularly in the Bergmann glia [11]. Brain calcification was observed in the thalamus of the Myorg knockout (KO) mouse model from approximately nine months of age, mimicking the phenotype in the PFBC patients. However, as a neurodegeneration progress, the Myorg-KO mouse models are difficult to study since brain calcification requires long observation periods, hindering the mechanistic studies of PFBC caused by loss of function of MYORG.

In this study, we applied a knockdown strategy to myorg by antisense oligonucleotides (ASO) in zebrafish. This model led to the development of calcified deposits in the brain, which could be mitigated by myorg cDNA supplement. In this case, the ASO-mediated knockdown strategy of myorg in zebrafish is another model for phenotypically and mechanistically studying PFBC, and possibly other neurodegenerative diseases.

Materials and methods

Zebrafish care and maintenance

Adult wild-type AB strain zebrafish were maintained at 28.5 ℃ on a 14/10 h light/dark cycle. Five to six pairs of zebrafish were paired for natural mating every generation. On average, 200–300 embryos were generated. Embryos were maintained at 28.5℃ in fish water (0.2% Instant Ocean Salt in deionized water). The embryos were washed and staged according to standard procedures [20]. The zebrafish facility at Shanghai Research Center for Model Organisms is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International.

Whole-mount in situ hybridization

The primers for the myorg and control probes produced from cDNA of zebrafish brain are as follows: myorg-pb-F: 5′-ATGGGAGTATGATGATGAGGTT-3′, myorg-pb-R: 5′-TAATACGACTCACTATAGGTTAAATGCAAGGCACGGA-3′, control-pb-F: 5′-TAATACGACTCACTATAGGATGGGAGTATGATGATGAGGTT-3′, control-pb-R: TTAAATGCAAGGCACGGA. This PCR product was transcribed for the digoxigenin (DIG)-labeled myorg RNA probe. The brains of adult zebrafish were isolated and fixed with 4% PFA, and used for the whole-mount in situ hybridization as previously reported [21].

qPCR analysis

Total RNA was isolated from adult zebrafish brains using the Trizol method. The RNA was reverse-transcribed to cDNA using a NovoScript® 1st Strand cDNA Synthesis SuperMix kit. qPCR was performed with a ChamQ SYBR qPCR Master Mix using Real-Time PCR System (Archimed, TMX4) with the following primers: myorg-RT-F: 5′-TGAAATGGTGAAGCCTAAAGAC-3′, myorg-RT-R: 5′-CCTGTTATGAAAGGTTTGGGTG-3; ef1α-RT-F: 5′-CTTCTCAGGCTGACTGTGC-3′, ef1α-RT-R: 5′-CCGCTAGCATTACCCTCC-3′. The data were analyzed with the baseline of Ct values, and each sample was measured with three replicates. And the relative myorg mRNA level was normalized to the ef1α.

MO microinjections and rescue assay

Gene Tools, LLC (http://www.gene-tools.com/) designed the morpholino (MO). Antisense MO (Gene Tools) were microinjected into fertilized one-cell stage embryos according to standard procedures [22]. The morpholino experiments were performed according to previously reported guidelines [23]. The sequences of the myorg splice-blocking sequence were 5′-TAAGCACCATCCATACTGACCTGAA-3′ (myorg-E2I2-MO), the myorg translation-blocking morpholinos were 5′-AGGCACTACCTGGTACATTCTGAAC-3′ (myorg-ATG-MO), and the standard control morpholinos were 5′-CCTCTTACCTCAGTTACAATTTATA-3′ (Control-MO). The amount of the MO used for injection was 4 ng per embryo. Total RNA was extracted from 30 to 50 embryos per group using TriPure Isolation Reagent (Roche) according to the manufacturer’s instructions. RNA was reverse-transcribed to cDNA using a PrimeScript RT Reagent Kit with gDNA Eraser (Takara). Primers spanning myorg Exon 1 (forward primer: 5′-ACACGAAACCAACAGTCCTC-3′) and Exon 3 (reverse primer: 5′-TCCTTTGGCTTCACTGTCATAA-3′) of myorg were used for transcript analysis to confirm the efficacy of the myorg-E2I2-MO. The primer ef1α sequences used as the internal control were 5′-GGAAATTCGAGACCAGCAAATAC-3′ (forward) and 5′-GATACCAGCCTCAAACTCACC-3′ (reverse).

For the rescue assay, 4 ng myorg-E2I2-MO was co-injected with 50 pg pcDNA3.1 containing zebrafish myorg cDNA per embryo, respectively. The coding region of the wild-type zebrafish myorg (ENSDART00000157837.2) was synthesized by Sangon Biotech and subcloned into the pcDNA3.1 vector (Invitrogen).

Calcein staining

Injected embryos were grown in 0.003% 1-phenyl-2-thiourea (PTU, Sigma, St. Louis, MO, USA) to block pigmentation and facilitate visualization until four days post-fertilization (dpf). After the treatment, zebrafish embryos (2–4 dpf) were washed three times with fish water and immersed in 0.2% calcein solution (C0875, Sigma-Aldrich) for 10 min. Next, zebrafish were thoroughly rinsed three times in fish water (5 min/wash) and anesthetized with 0.016% MS-222 (tricaine methanesulfonate, Sigma-Aldrich, St. Louis, MO, USA). The zebrafish were then oriented on their dorsal and lateral side and mounted with 3% methylcellulose (Sigma-Aldrich, St. Louis, MO, USA) in a depression slide for observation by fluorescence microscopy. The fluorescent chromophore, Calcein (C30H26N2O13), specifically binds to calcium, fluorescently staining the calcified structures in living zebrafish larvae and juveniles. This allowed us to analyze brain calcifications in live zebrafish with high sensitivity [24]. Zebrafish brain calcifications were also visible as bright green spots. The number of brain calcifications was quantitatively analyzed at different time points.

Image acquisition

Embryos and larvae were analyzed using a Nikon SMZ 1500 Fluorescence microscope and subsequently photographed with digital cameras. A subset of images was adjusted for levels, brightness, contrast, hue, and saturation with Adobe Photoshop 7.0 software (Adobe, San Jose, CA, USA) to optimally visualize the expression patterns. Positive signals were defined by manually counting the number of green punctae using Image J. Ten zebrafish for each treatment were quantified, and we calculated the averaged total signal per animal.

Statistical analysis

All data were presented as mean ± SEM. Statistical analysis and graphical representation of the data were performed using GraphPad Prism 7.0 (GraphPad Software, San Diego, CA, USA). Statistical significance was performed using a Student’s t-test, where appropriate. Statistical significance is indicated by *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.

Results

myorg expression analysis in zebrafish

The myorg protein sequence shows about 67%~68% identity between the zebrafish and human or mice using BLAST, which could be regarded as average to high conservation between those species. (Fig. 1A). To analyze the myorg expression pattern in zebrafish, we first performed the whole-mount in situ hybridization and quantitative mRNA analysis of the zebrafish brain. myorg mRNA was highly expressed in the cerebellum in the central nervous system (Fig. 1B, C) in zebrafish, while myorg was most highly expressed in the muscle in the peripheral tissues (Fig. 1C). Also, myorg mRNA exhibited relative abundant expression in the hypothalamus, medulla oblongata, eyes, kidney, and intestine, but had low expression levels in the heart (Fig. 1C; Additional file 1: Table S1). The myorg expression pattern in zebrafish was similar to that of mice, especially in the brain [11].

Fig. 1
figure 1

Expression pattern of myorg in zebrafish. A Sequence analysis of homology of amino acids of MYORG among different species (https://www.ncbi.nlm.nih.gov/gene/57462/ortholog/?scope=7776&term=MYORG). The color code legends could be found at the NCBI database (https://www.ncbi.nlm.nih.gov/tools/msaviewer/tutorial1/#conservation). B Whole-mount in situ hybridization analysis of myorg in the zebrafish brain. White arrows indicate the regions of positive signals. C The quantitative real-time PCR analysis of myorg in different tissues in zebrafish. Means ± SEM, n ≥ 3, Student’s t-test. Scale bar, 50 μm. DV dorsal view, LV lateral view

Full size image

As the Expression Atlas database (https://www.ebi.ac.uk/gxa/home) displayed, myorg is highly expressed in the development periods from blastula to larval day 5 except for few stages (like segmentation 14–17 somites and pharyngula prim-25) (Additional file 1: Fig. S1). A single-cell transcriptome atlas for zebrafish development suggested that the distribution of myorg RNA ranged from different cell types, including neuroblasts, neuron, cranial neural crest, and glial cells [25]. Collectively, myorg expressed broadly in the brain of zebrafish, including the critical regions, stages, and cell types.

Calcification deposits in myorg knockdown zebrafish

We previously found that Myorg-KO mice could develop brain calcifications in the thalamus when they were nine months old. To examine the loss-of-function effect of myorg in zebrafish, we designed and injected zebrafish with an antisense oligo targeting Exon 2 and Intron 2 (E2I2-MO) of myorg to block its splicing sites (Fig.  2Aa). The effectiveness of myorg knockdown was confirmed by PCR of cDNA after morpholino injection of zebrafish larvae at 2 dpf (Fig. 2B). As a comparison, e1fα showed similar transcript abundance under both the myorg-E2I2-MO and Control-MO intervention (Fig. 2B). Sanger sequencing also validated that E2I2-MO resulted in a complete skipping of Exon 2 in the transcript (Fig. 2C), leading to a knockdown of myorg in zebrafish. We also utilized another morpholino targeting the start codon of myorg (ATG-MO), in order to prevent the protein expression by blocking its translation initiation (Fig. 2Ab).

Fig. 2
figure 2

myorg knockdown showed brain calcifications in zebrafish. A Schematic depiction of the myorg transcript after E2I2-MO (a) and ATG-MO (b) administration. B The effectiveness of myorg knockdown was confirmed by RT-PCR after morpholino injection of zebrafish larvae at 2 dpf. Injection of 4 ng of myorg morpholino altered the splicing between Exon 2 and Intron 2, as revealed by a shift in PCR bands between control (619 bp) and myorg morpholino injected embryos (137 bp). C Sanger sequencing confirmed the transcription of skipping Exon 2 after the injection of myorg-E2I2-MO. dpf, days post-fertilization. D Dorsal views of zebrafish embryos injected with control morpholino oligonucleotides (Control-MO), myorg-E2I2-MO, and myorg-ATG-MO. MO injected embryos were stained with calcein at 3 dpf. Compared to Control-MO (a–c), myorg-E2I2-MO (d–f), and myorg-ATG-MO (g–i) showed potent brain calcifications as green fluorescence in the zebrafish brain. (a, d, g) bright field; (b, e, h) calcein staining; the magnified zooms of the red dashed box are shown in c, f, i. E Quantification of the brain calcifications in the myorg-E2I2-MO and myorg-ATG-MO injected zebrafish at 3 dpf compared to that in Control-MO injected zebrafish. F Time-course analysis of brain calcifications in the myorg-E2I2-MO knockdown zebrafish. Means ± SEM, n = 10, Student’s t-test, ****P < 0.0001, ***P < 0.001, **P < 0.01. Scale bar, 50 μm. dpf days post-fertilization

Full size image

We observed the calcifications in the head of myorg knockdown zebrafish before skeletal formation around 5 dpf using calcein, a calcium-binding fluorescent chromophore. The fluorescent chromophore, calcein (C30H26N2O13), specifically binds to calcium, fluorescently staining the calcified structures and allowing for highly sensitive analysis of brain calcifications in live zebrafish larvae [24]. After microinjection of the myorg-E2I2-MO and myorg-ATG-MO into fertilized one-cell stage embryos, the calcification number in the myorg-knockdown zebrafish brain was 35.6 (11–80) and 10.6 (9–13), respectively, compared to the control group value of 1.1 (0–2) in 3 dpf zebrafish (Fig. 2D, E; Table 1). The number of brain calcification deposits caused by myorg-E2I2-MO were more than that by myorg-ATG-MO. We also observed that the number of green fluorescent signals was consistently increased during 2–4 dpf after microinjection of the myorg-E2I2-MO, while the size of calcification nodules was uniform (Fig. 2F). Indeed, the myorg-knockdown zebrafish became weak after myorg-E2I2-MO and myorg-ATG-MO injection, and they could not survive longer than about one week. Collectively, we confirmed that calcified deposits developed in the myorg knockdown zebrafish brains before 5 dpf using two kinds of morpholino-mediated strategies.

Table 1 Number of calcification nodules in myorg knockdown zebrafish at 3 dpf (10 embryos for each group)
Full size table

myorg cDNA rescued the E2I2-MO induced brain calcification

To verify the calcification phenotype using myorg-knockdown strategies in zebrafish, we performed the rescue assay to confirm its accuracy. We synthesized the myorg cDNA and cloned it into the pcDNA3.1 vector, then co-injected it, along with myorg-E2I2-MO, into zebrafish embryos. Compared to the myorg-E2I2-MO alone, administering E2I2-MO and myorg cDNA plasmid decreased calcification deposits at 3 dpf (Fig. 3A, B). Based on E2I2-MO knockdown, the number of calcification nodules is around 1.7 (0–3) after myorg cDNA replenishment, which is close to the effect resulting from Control-MO (Fig. 3B). In conclusion, our data confirmed that knockdown of myorg in zebrafish could develop brain calcification, and this phenotype could be mitigated by myorg cDNA compensation.

Fig. 3
figure 3

myorg cDNA rescued the E2I2-MO induced calcification phenotype. A Dorsal views of zebrafish embryos injected with control morpholino oligonucleotides (Control-MO), myorg-E2I2-MO, and E2I2-MO combined with myorg cDNA. These embryos were stained with calcein at 3 dpf. Compared to Control-MO (a–c), myorg-E2I2-MO showed potent brain calcifications as green fluorescence in the zebrafish brain (d–f), E2I2-MO plus myorg cDNA resulted in reduced calcification nodules (g–i). a, d, g bright field; b, e, h calcein staining; the merged images are shown in c, f, i. B Quantification of the calcification number in the brain in myorg-E2I2-MO with or without myorg cDNA injection to zebrafish at 3 dpf compared to that in Control-MO injected zebrafish. Means ± SEM, n = 10, Student’s t-test, ****P < 0.0001. Scale bar, 50 μm

Full size image

Discussion

The specific function of MYORG in PFBC remains unclear, meaning that animal models simulating PFBC-like brain calcifications could help elucidate the mechanism of PFBC and relevant therapies. In this study, we demonstrate that knockdown of myorg in zebrafish by ASO could successfully mimic the brain calcification phenotype, which could serve as another animal model for assessing MYORG-associated brain calcification.

Of the six causative genes, we reported that MYORG was the first and most prevalent pathogenic gene in autosomal recessive PFBC [26, 27]. Gene knockout mice were mostly used to mimic the phenotype of PFBC patients. However, neurodegenerative disorders progress relatively slowly, which extends the time required to observe phenotypes such as brain calcifications. Using histological staining, Slc20a2-KO mice exhibited relatively obvious calcified nodules at 15 weeks old, which is one of the earliest emerging PFBC mouse models [28]. Similarly, the Pdgfbret/ret mice developed brain calcifications at two months old [9]. We observed the calcified deposits in the thalamus around the nine months old in Myorg-KO mice [11]. Nevertheless, no obvious brain calcification phenotypes were present in the Pdgfrb and Jam2 knockout mouse models until they were 14 and 18 months old, respectively [16, 29]. To some extent, our myorg-knockdown zebrafish could mimic the brain calcification phenotype at an early age before skull formation, which could accelerate the emergence of the diagnostic phenotype and facilitate mechanistic studies.

Zebrafish can be used to simulate disease-associated phenotypes in mammalian species [30,31,32]. Using zebrafish as a model has several advantages, including their small size, easy maintenance, fast growth, and short generational time, etc. In particular, embryo zebrafish appear to be transparent, which is advantageous for monitoring the development or pathogenic states of certain organs, such as the complicated central nervous system (CNS), while zebrafish also provide a tractable system for measuring certain behaviors [33]. To date, zebrafish have been used to explore CNS disorders, including autism spectrum disorders, cerebrovascular disorders, neuromuscular diseases, epilepsy, hereditary spastic paraplegia, and neurodegenerative diseases [34,35,36,37,38,39]. Our findings indicate that brain calcification deposits could be detected in the zebrafish embryos before the skeletal system forms, which could make them a complementary model similar to above-mentioned PFBC mouse models.

Gene knockdown has been widely used to mimic clinical phenotypes in zebrafish [22], especially the antisense oligo blocking strategy. In comparison, gene knockout zebrafish models have been demonstrated to produce genetic compensation response (GCR), which depends on premature termination codons or the homology of transgene sequence with the compensatory endogenous genes [40]. Alleles that are transcribed in response to the deleterious mutation could display more severe phenotypes than alleles with mutant mRNA decay since they can escape the transcriptional adaptation [41]. Morpholino delivery to zebrafish can rapidly model the disease phenotype and potentially avoid the phenotype discrepancies. Knockdown zebrafish models have been used to successfully mimic the typical phenotypes of neutrophil defect syndrome, early-onset stroke and vasculopathy, cerebral small-vessel disease, macular degeneration, adolescent idiopathic scoliosis, and limb-girdle muscular dystrophy [36, 37, 42,43,44,45]. We applied the ASO strategy to zebrafish zygotes and observed multiple calcified nodules in the brain parenchyma of myorg knockdown zebrafish, and the calcification nodules were persistent at least in 2–4 dpf, successfully modeling the PFBC phenotype. We also rescued the phenotype by supplementing the myorg cDNA, which served as a key control to validate the fidelity of brain calcification in myorg-knockdown zebrafish. However, the knockdown strategy also has limitations, for example, ASO knockdown effects cannot be steadily passed on to its offspring, and the myorg-knockdown zebrafish could not survive more than one week because of the inability to obtain feed. This hinders us from continuously tracking the pathogenic characteristics.

Conventional calcification detection methods have used histochemical stainings including Alcian blue, Alizarin red, and Von Kossa. The widespread calcification in vasculature could be observed in the α-klotho knockout zebrafish at five months old [46]. However, it is also confirmed that Alcian blue and Alizarin red are not sensitive enough to recognize the calcified bone structure in zebrafish embryos [24]. Our myorg knockdown larval zebrafish is more fragile with PFA fixing when prepared for immunohistochemical staining, which hinders us from recognizing their physical structures. Accordingly, the results were not stable. Compared to the above two bone markers, calcein staining is more convenient, inclusive, and accurate without toxicity in a live state.

In summary, we established zebrafish as a novel model to simulate brain calcifications in animals other than mice. Our results demonstrate that knockdown of myorg by ASO could lead to calcification in the brain of zebrafish embryos. This could promote further study of the molecular mechanisms and precise therapies for PFBC.

Availability of data and materials

All experimental protocols are described in the “Materials and methods” section or in the references therein, and resources are available upon request from the corresponding authors XPY and WJC.

Abbreviations

PFBC:

Primary familial brain calcification

dpf:

Days post-fertilization

ASO:

Antisense oligonucleotides

BBB:

Blood–brain barrier

CNS:

Central nervous system

GCR:

Genetic compensation response

References

  1. Mann DMA. Calcification of the basal ganglia in Down’s syndrome and Alzheimer’s disease. Acta Neuropathol. 1988;76:595–8.

    Article  CAS  PubMed  Google Scholar 

  2. Vermersch P, Leys D, Pruvo JP, Clarisse J, Petit H. Parkinson’s disease and basal ganglia calcifications: prevalence and clinico-radiological correlations. Clin Neurol Neurosurg. 1992;94:213–7.

    Article  CAS  PubMed  Google Scholar 

  3. Chen S, Cen Z, Fu F, Chen Y, Chen X, Yang D, et al. Underestimated disease prevalence and severe phenotypes in patients with biallelic variants: a cohort study of primary familial brain calcification from China. Park Relat Disord. 2019;64:211–9.

    Article  Google Scholar 

  4. Quintáns B, Oliveira J, Sobrido MJ. Primary familial brain calcifications. Handb Clin Neurol. 2018;147:307–17.

    Article  PubMed  Google Scholar 

  5. Nicolas G, Pottier C, Charbonnier C, Guyant-Maréchal L, Le Ber I, Pariente J, et al. Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification. Brain. 2013;136:3395–407.

    Article  PubMed  Google Scholar 

  6. Kobayashi S, Yamadori I, Miki H, Ohmori M. Idiopathic nonarteriosclerotic cerebral calcification (Fahr’s disease): an electron microscopic study. Acta Neuropathol. 1987;73:62–6.

    Article  CAS  PubMed  Google Scholar 

  7. Wang C, Li Y, Shi L, Ren J, Patti M, Wang T, et al. Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis. Nat Genet. 2012;44:254–6.

    Article  CAS  PubMed  Google Scholar 

  8. Nicolas G, Pottier C, Maltête D, Coutant S, Rovelet-Lecrux A, Legallic S, et al. Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification. Neurology. 2013;80:181–7.

    Article  CAS  PubMed  Google Scholar 

  9. Keller A, Westenberger A, Sobrido MJ, García-Murias M, Domingo A, Sears RL, et al. Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice. Nat Genet. 2013;45:1077–82.

    Article  CAS  PubMed  Google Scholar 

  10. Legati A, Giovannini D, Nicolas G, López-Sánchez U, Quintáns B, Oliveira JRM, et al. Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export. Nat Genet. 2015;47:579–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Yao XP, Cheng X, Wang C, Zhao M, Guo XX, Su HZ, et al. Biallelic mutations in MYORG cause autosomal recessive primary familial brain calcification. Neuron. 2018;98:1116-1123.e5.

    Article  CAS  PubMed  Google Scholar 

  12. Cen Z, Chen Y, Chen S, Wang H, Yang D, Zhang H, et al. Biallelic loss-of-function mutations in JAM2 cause primary familial brain calcification. Brain. 2020;143:491–502.

    Article  PubMed  Google Scholar 

  13. Wallingford MC, Chia JJ, Leaf EM, Borgeia S, Chavkin NW, Sawangmake C, et al. SLC20A2 deficiency in mice leads to elevated phosphate levels in cerbrospinal fluid and glymphatic pathway-associated arteriolar calcification, and recapitulates human idiopathic Basal Ganglia calcification. Brain Pathol. 2017;27:64–76.

    Article  CAS  PubMed  Google Scholar 

  14. Giovannini D, Touhami J, Charnet P, Sitbon M, Battini JL. Inorganic phosphate export by the retrovirus receptor XPR1 in metazoans. Cell Rep. 2013;3:1866–73.

    Article  CAS  PubMed  Google Scholar 

  15. Betsholtz C, Keller A. PDGF, pericytes and the pathogenesis of idiopathic basal ganglia calcification (IBGC). Brain Pathol. 2014;24:387–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Schottlaender LV, Abeti R, Jaunmuktane Z, Macmillan C, Chelban V, O’Callaghan B, et al. Bi-allelic JAM2 variants lead to early-onset recessive primary familial brain calcification. Am J Hum Genet. 2020;106:412–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Schirmer EC, Florens L, Guan T, Yates JR, Gerace L. Nuclear membrane proteins with potential disease links found by subtractive proteomics. Science. 2003;301:1380–2.

    Article  CAS  PubMed  Google Scholar 

  18. Chen IHB, Huber M, Guan T, Bubeck A, Gerace L. Nuclear envelope transmembrane proteins (NETs) that are up-regulated during myogenesis. BMC Cell Biol. 2006;7:1–16.

    Article  CAS  Google Scholar 

  19. Datta K, Guan T, Gerace L. NET37, a nuclear envelope transmembrane protein with glycosidase homology, is involved in myoblast differentiation. J Biol Chem. 2009;284:29666–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. Stages of embryonic development of the zebrafish. Dev Dyn. 1995;203:253–310.

    Article  CAS  PubMed  Google Scholar 

  21. Thisse B, Heyer V, Lux A, Alunni V, Degrave A, Seiliez I, et al. Spatial and temporal expression of the zebrafish genome by large-scale in situ hybridization screening. Methods Cell Biol. 2004;77:505–19.

    Article  CAS  PubMed  Google Scholar 

  22. Nasevicius A, Ekker SC. Effective targeted gene “knockdown” in zebrafish. Nat Genet. 2000;26:216–20.

    Article  CAS  PubMed  Google Scholar 

  23. Stainier DYR, Raz E, Lawson ND, Ekker SC, Burdine RD, Eisen JS, et al. Guidelines for morpholino use in zebrafish. PLoS Genet. 2017;13:6–10.

    Article  CAS  Google Scholar 

  24. Jun Du S, Frenkel V, Zohar Y, Kindschi G. Visualizing normal and defective bone development in zebrafish embryos using the fluorescent chromophore calcein. Dev Biol. 2001;238:239–46.

    Article  CAS  Google Scholar 

  25. Farnsworth DR, Saunders LM, Miller AC. A single-cell transcriptome atlas for zebrafish development. Dev Biol. 2020;459:100–8.

    Article  CAS  PubMed  Google Scholar 

  26. Alvarez-Fischer D, Westenberger A. Biallelic MYORG mutations: primary familial brain calcification goes recessive. Mov Disord. 2019;34:322.

    Article  PubMed  Google Scholar 

  27. Bauer M, Rahat D, Zisman E, Tabach Y, Lossos A, Meiner V, et al. MYORG mutations: a major cause of recessive primary familial brain calcification. Curr Neurol Neurosci Rep. 2019;19:70.

    Article  PubMed  CAS  Google Scholar 

  28. Jensen N, Schrøder HD, Hejbøl EK, Thomsen JS, Brüel A, Larsen FT, et al. Mice knocked out for the primary brain calcification–associated gene Slc20a2 show unimpaired prenatal survival but retarded growth and nodules in the brain that grow and calcify over time. Am J Pathol. 2018;188:1865–81.

    Article  CAS  PubMed  Google Scholar 

  29. Vanlandewijck M, Lebouvier T, Mäe MA, Nahar K, Hornemann S, Kenkel D, et al. Functional characterization of germline mutations in PDGFB and PDGFRB in primary familial brain calcification. PLoS ONE. 2015;10:1–25.

    Article  CAS  Google Scholar 

  30. Santoriello C, Zon LI. Hooked! modeling human disease in zebrafish. J Clin Invest. 2012;122:2337–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Zon LI, Peterson RT. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov. 2005;4:35–44.

    Article  CAS  PubMed  Google Scholar 

  32. Lieschke GJ, Currie PD. Animal models of human disease: zebrafish swim into view. Nat Rev Genet. 2007;8:353–67.

    Article  CAS  PubMed  Google Scholar 

  33. Fontana BD, Mezzomo NJ, Kalueff AV, Rosemberg DB. The developing utility of zebrafish models of neurological and neuropsychiatric disorders: a critical review. Exp Neurol. 2018;299:157–71.

    Article  PubMed  Google Scholar 

  34. Meshalkina DA, Kizlyk N, Kysil MV, Collier E, Echevarria AD, Abreu DJ, et al. Zebrafish models of autism spectrum disorder. Exp Neurol. 2018;299:207–16.

    Article  CAS  PubMed  Google Scholar 

  35. Lin X, Su HZ, Dong EL, Lin XH, Zhao M, Yang C, et al. Stop-gain mutations in UBAP1 cause pure autosomal-dominant spastic paraplegia. Brain. 2019;142:2238–52.

    Article  PubMed  Google Scholar 

  36. Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370:911–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Carss KJ, Stevens E, Foley AR, Cirak S, Riemersma M, Torelli S, et al. Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan. Am J Hum Genet. 2013;93:29–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Xi Y, Noble S, Ekker M. Modeling neurodegeneration in zebrafish. Curr Neurol Neurosci Rep. 2011;11:274–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Grone BP, Baraban SC. Animal models in epilepsy research: legacies and new directions. Nat Neurosci. 2015;18:339–43.

    Article  CAS  PubMed  Google Scholar 

  40. Ma Z, Zhu P, Shi H, Guo L, Zhang Q, Chen Y, et al. PTC-bearing mRNA elicits a genetic compensation response via Upf3a and COMPASS components. Nature. 2019;568:259–63.

    Article  CAS  PubMed  Google Scholar 

  41. El-Brolosy MA, Kontarakis Z, Rossi A, Kuenne C, Günther S, Fukuda N, et al. Genetic compensation triggered by mutant mRNA degradation. Nature. 2019;568:193–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Vilboux T, Lev A, Malicdan MCV, Simon AJ, Järvinen P, Racek T, et al. A congenital neutrophil defect syndrome associated with mutations in VPS45. N Engl J Med. 2013;369:54–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. French C, Seshadri S, Destefano A, Fornage M, Arnold C, Gage P, et al. Mutation of FOXC1 and PITX2 induces cerebral small-vessel disease. Clin J. 2014;124:4877–81.

    CAS  Google Scholar 

  44. Van De Ven JPH, Nilsson SC, Tan PL, Buitendijk GHS, Ristau T, Mohlin FC, et al. A functional variant in the CFI gene confers a high risk of age-related macular degeneration. Nat Genet. 2013;45:813–7.

    Article  PubMed  CAS  Google Scholar 

  45. Kou I, Takahashi Y, Johnson TA, Takahashi A, Guo L, Dai J, et al. Genetic variants in GPR126 are associated with adolescent idiopathic scoliosis. Nat Genet. 2013;45:676–9.

    Article  CAS  PubMed  Google Scholar 

  46. Singh AP, Sosa MX, Fang J, Shanmukhappa SK, Hubaud A, Fawcett CH, et al. αKlotho regulates age-associated vascular calcification and lifespan in zebrafish. Cell Rep. 2019;28:2767-2776.e5.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was supported by the grants 82025012 (W.-J.C.), U1905210 (W.-J.C.) 82171841 (X.-P.Y.), and 81901158 (C.W.) from the National Natural Science Foundation of China, the Natural Science Foundation of Fujian Province 2019J02010 (W.-J.C.) and 2021J01221 (M.Z.), the Joint Funds for the Innovation of Science and Technology, Fujian Province 2020Y9118 (X.-P.Y.), China Postdoctoral Science Foundation 2022M710704 (M.Z.), the Post-doctoral Startup Fund for Scientific Research of the First Affiliated Hospital of Fujian Medical University BSH3606 (M.Z.), and the Scientific Research Foundation for the Introduction of Talent of the First Affiliated Hospital of Fujian Medical University (M.Z.).

Author information

Author notes

  1. Miao Zhao, Xiao-Hong Lin and Yi-Heng Zeng contributed equally

Authors and Affiliations

  1. Department of Neurology, Institute of Neurology of First Affiliated Hospital, Institute of Neuroscience, and Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, 350005, China

    Miao Zhao, Xiao-Hong Lin, Yi-Heng Zeng, Hui-Zhen Su, Chong Wang, Kang Yang, Yi-Kun Chen, Bi-Wei Lin, Xiang-Ping Yao & Wan-Jin Chen

Authors
  1. Miao Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiao-Hong Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yi-Heng Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hui-Zhen Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kang Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yi-Kun Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bi-Wei Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Xiang-Ping Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Wan-Jin Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

WJC, XPY, and MZ designed and supervised the study, and drafted the manuscript. WJC critically revised the important intellectual content of the manuscript. MZ, XHL, and YHZ generated and collected data, designed and made diagrams, and performed analyses and interpretation. HZS, CW, KY, YKC, and BWL collected data and provided technical support. The final version of the manuscript was approved by all authors. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Xiang-Ping Yao or Wan-Jin Chen.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Institutional Ethnics Committee of the First Affiliated Hospital of Fujian Medical University (MRCTA, ECFAH of FMU [2019]198).

Consent for publication

Not applicable.

Competing interests

The authors declare no competing or financial interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1: Fig. S1.

myorg expression of zebrafish in different developing stages (https://www.ebi.ac.uk/gxa/home). Table S1. The mean Ct values for myorg and ef1α mRNA expression in different regions of adult zebrafish.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, M., Lin, XH., Zeng, YH. et al. Knockdown of myorg leads to brain calcification in zebrafish. Mol Brain 15, 65 (2022). https://doi.org/10.1186/s13041-022-00953-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13041-022-00953-4

Keywords

  • Primary familial brain calcification
  • Myorg
  • Zebrafish
  • Antisense oligo
  • Knockdown

Molecular Brain

ISSN: 1756-6606